Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
A zero-based budget ensures every dollar is assigned a purpose. Learn how this budgeting method can help you maximize your financial resources.
16,798 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Howard Lindzon’s work with StockTwits and Social Leverage reshapes how we think about investing in communities. This ...
A Qatar-linked LNG carrier crossed Hormuz, the first export through the strait since the war intensified. The move co...
A 25-year-old CEO leads a bold new player into federal banking with an OCC charter and a $40 million funding round, s...
SpaceX IPO excitement can tempt any investor, but the space sector is risky and competitive. This guide compares Spac...
What really moved Si-Bone in Q1 2026? Our practical analysis breaks down revenue trends, margins, and the company’s a...
Analysts are watching every cue as Apple navigates leadership shifts and growth bets. This article breaks down what a...
Tesla posts stronger AI-driven software and cash flow, while Rivian reports revenue with mounting automotive losses. ...
IonQ posted a 755% YoY jump in Q1 2026 revenue to $64.67 million, but mounting losses and burn risk cast doubt on the...
A Seoul hotel launches a robot napkin-folding pilot, part of a broader push into physical AI that blends staff skills...
Lenders are racing to scale content with AI, but a growing wave of complaints cites a loss of trust and rising compli...
Metaplanet, the nation’s largest corporate bitcoin holder outside the United States, posted a hefty quarterly loss ti...